Seqster Bags Investment to Enhance Clinical Trials

Seqster Bags Investment to Enhance Clinical Trials

Seqster has secured investments to boost the adoption of its interoperability technology to enhance clinical trials, patient engagement, and outcomes.

FREMONT, CA: "We are thrilled to have Takeda Pharmaceuticals as a strategic investor sharing our vision and mission of putting patients at the center of all of their health data and making health data into medicine," says Ardy Arianpour, CEO of Seqster. The award-winning SaaS-based technology platform enabling person-centric health data management, Seqster, has raised investment from Takeda Pharmaceuticals, a global, value-based, R&D-driven biopharmaceutical leader headquartered in Japan. Funds that the company received will be used to accelerate the adoption of Seqster's interoperability technology for enhancing clinical trials, patient engagement, and outcomes.

Ardy adds, "We have created a unique data-sharing environment that retrieves, parses and harmonizes multi-dimensional data sets thereby accelerating the entire drug development process with high fidelity data hosted within a HIPAA-compliant and HiTrust data schema. Seqster provides clinical trial participants a secure platform to consent and share their data with investigators and study personnel in real-time, creating a longitudinal health record that facilitates patient clinical trial onboarding, monitoring, and post-trial follow-ups."

Seqster is thrilled to have Takeda Pharmaceuticals as a strategic investor, sharing the same vision and mission of putting patients at the center of all of their health data and making health data into medicine. The company has created a unique data-sharing environment that retrieves, parses, and harmonizes multi-dimensional data sets. The data accelerates the entire drug development process with high fidelity data hosted within a HIPAA-compliant and HiTrust data schema. Seqster offers clinical trial participants a secure platform to consent and share their data with investigators. The company also lets the participants study personnel in real-time creating a longitudinal health record that facilitates patient clinical trial onboarding, monitoring, and post-trial follow-ups.

Seqster provides SaaS-based healthcare solutions enabling organizations to drive efficient healthcare through comprehensive medical records, individual genomic profiles, and personal health device data. For the first time, users can create their own matched, longitudinal health data profile over all of their US-based healthcare data sources through person-centric interoperability. Seqster helps healthcare providers and payers onboard their members efficiently and accurately by seamlessly integrating with any payer, provider, or clinical research enterprise.